EKF Diagnostics’ novel diabetic biomarker test successfully externally verified

Glycated Serum Protein assay provides simple, sensitive and fast alternative glycemic monitoring test.

EKF diagnostics diabetic biomarker test

EKF’s GSP assay bridges the gap in diabetes testing in cases where HbA1c cannot be reliably measured

EKF Diagnostics, the global in vitro diagnostics company, announces that its newly introduced Glycated Serum Protein (GSP) LiquiColor® diabetic biomarker test has been verified for use on the Siemens Vista chemistry analyzer.

In a scientific poster published by scientists at the Memorial Healthcare System, Hollywood, USA [1], it was demonstrated that EKF’s GSP assay enhances the versatility of the Vista system for the specialized glycemic monitoring of diabetics with hemoglobinopathies, or conditions that affect red blood cell (RBC) lifespan.

Daily blood glucose and HbA1c are used as short and long term (3-4 month) measures of glycemic control respectively. However, HbA1c values may be adversely affected by patients with hemoglobin variants or conditions that affect RBC lifespan such as anemia and dialysis to name a few, while GSP as a 2-3 week indicator of blood glucose, is unaffected.

Traditional NBT assays for fructosamine (or GSP), used as an alternative test for diabetes patients with hemoglobinopathies and pregnant women, suffer from a variety of interferences. Due to these analytical issues, the Memorial Healthcare System scientists required a reliable alternative that could be adapted to their existing analyzer. Therefore, the EKF Diagnostics GSP assay was evaluated and validated using an open channel user defined method.

The scientific poster authors concluded that EKF’s GSP assay provides laboratories with a simple, sensitive and fast alternative glycemic monitoring test without the endogenous substance interference that are typically observed in NBT based colorimetric assays.

 

We are pleased with the recognition by the Memorial Health System of the value of our GSP diabetic biomarker test which is based on a double enzymatic degradation method. This provides superior specificity, accuracy and reliability compared to the older non-enzymatic fructosamine NBT method,”

said Al Blanco, Business Unit Director – Central Lab at EKF Diagnostics.

He added, "As a 2-3 week indicator of average blood glucose which is unaffected by RBC half-life, GSP closes the information gap between daily blood glucose and HbA1c testing. This means that GSP serves as an accurate intermediate marker of glycemia in instances where HbA1c may be of limited value, such as pregnancy, reduced RBC lifespan and hemodialysis.”

The Memorial Health System scientific poster presented at the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting 2016 is available to view at: http://www.ekfdiagnostics.com/glycated-serum-protein.html.

For more information on EKF Diagnostics, please see www.ekfdiagnostics.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    EKF Diagnostics. (2017, August 03). EKF Diagnostics’ novel diabetic biomarker test successfully externally verified. News-Medical. Retrieved on May 25, 2019 from https://www.news-medical.net/news/20161018/EKF-Diagnosticse28099-novel-diabetic-biomarker-test-successfully-externally-verified.aspx.

  • MLA

    EKF Diagnostics. "EKF Diagnostics’ novel diabetic biomarker test successfully externally verified". News-Medical. 25 May 2019. <https://www.news-medical.net/news/20161018/EKF-Diagnosticse28099-novel-diabetic-biomarker-test-successfully-externally-verified.aspx>.

  • Chicago

    EKF Diagnostics. "EKF Diagnostics’ novel diabetic biomarker test successfully externally verified". News-Medical. https://www.news-medical.net/news/20161018/EKF-Diagnosticse28099-novel-diabetic-biomarker-test-successfully-externally-verified.aspx. (accessed May 25, 2019).

  • Harvard

    EKF Diagnostics. 2017. EKF Diagnostics’ novel diabetic biomarker test successfully externally verified. News-Medical, viewed 25 May 2019, https://www.news-medical.net/news/20161018/EKF-Diagnosticse28099-novel-diabetic-biomarker-test-successfully-externally-verified.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
EKF introduces new hand-held lactate analyzer for rapid sports performance monitoring